Triclabendazole

Kathryn Dzintars, PharmD, BCPS
Triclabendazole is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

Triclabendazole is not currently FDA approved for use in the United States.

  • Available through the CDC under an investigational drug protocol
  • Triclabendazole is included on the WHO Essential Drug List for the management of fascioliasis.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: October 25, 2016

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Triclabendazole ID - 540674 A1 - Dzintars,Kathryn,PharmD, BCPS Y1 - 2016/10/25/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540674/all/Triclabendazole PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -